Chemomab Therapeutics Ltd. (CMMB) Financials
CMMB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 23.4 million | 5.4 million |
2023-06-30 | 28.8 million | 6.9 million |
2023-03-31 | 35.0 million | 7.1 million |
2022-12-31 | 43.1 million | 6.8 million |
CMMB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -5.1 million | ? |
2023-06-30 | -7.5 million | 639000 |
2023-03-31 | -7.2 million | 484000 |
2022-12-31 | -5.7 million | 740000 |
CMMB Net Income
No data available :(
CMMB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 21.4 million | - | - |
2023-06-30 | 26.6 million | - | 141000 |
2023-03-31 | 32.7 million | - | 177000 |
2022-12-31 | 39.9 million | - | 214000 |
CMMB Shares Outstanding
CMMB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 6 | 3.3 million | - | - |
2023-06-30 | 2000 | 5.0 million | 3.2 million | - |
2023-03-31 | 1000 | 6.9 million | 2.2 million | - |
2022-12-31 | 1000 | 5.9 million | 2.7 million | - |
CMMB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 18938 |
2023-06-30 | - | 15818 |
2023-03-31 | - | 9.0 million |
2022-12-31 | - | 13962 |
CMMB
Price: $0.73
52 week price:
Earnings Per Share: -2.94 USD
P/E Ratio: -0.20
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 37000
Market Capitalization: 10.4 million